Big pharma rediscovers the poultry industry

The recent announcement that Pfizer Animal Health will purchase Embrex Inc. for over $150 million is an encouraging sign that multi-national pharmaceutical companies are re-evaluating the importance of the poultry industry.  By Simon Shane While there is some speculation in the US as to the motivation for the purchase of Embrex , the leading supplier of in ovo injection equipment, it is evident that strategists at Pfizer Animal Health intend to broaden their product-market scope.  Thi